Exchange: NASDAQ·Updated 09:45 AM EDT
SLGL logo

SLGL Sol-Gel Technologies Ltd

$69.04
$0.48
(0.69%)
Today
Reported EarningsAug 20
Mkt Cap$227.61M
Vol843.00

About SLGL

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
58

Bullish Sentiment

How do you feel about SLGL?

Advertisement|Remove ads.